Scientific publications

Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

Feb 23, 2024 | Magazine: Gut

Francisco Javier Cubero 1 2, Pablo Sarobe 3 4 5, Gisa Tiegs 6

Abstract

No abstract available

CITA DEL ARTÍCULO Gut. 2024 Feb 23;73(3):391-392. doi: 10.1136/gutjnl-2023-331048.

see publication in pubmed

Our authors

Dr. Pablo Sarobe Ugarriza Curriculum
Researcher | Principal Investigator Vaccine Development Research Group